Repurposing Phosphodiesterase-5 inhibitors as chemoadjuvants
Main Authors: | Amit K. Tiwari, Zhe-Sheng eChen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00082/full |
Similar Items
-
Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
by: Arman Shafiee, et al.
Published: (2023-05-01) -
Phosphodiesterase 5 inhibitors attenuate renal tubular apoptosis after partial unilateral ureteral obstruction: An experimental study
by: Turgay Akgül, et al.
Published: (2011-01-01) -
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
by: Jens Schlossmann, et al.
Published: (2013-02-01) -
No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma
by: Jenny Z. Wang, et al.
Published: (2019-09-01) -
Phosphodiesterase Type 5 Inhibitors Greatly Affect Physicochemical Properties of Model Lipid Membranes
by: Anastasiia A. Zakharova, et al.
Published: (2021-11-01)